WVE logo

Wave Life Sciences Ltd. (WVE) Cash from financing

annual CFF:

$253.89M+$121.36M(+91.57%)
December 31, 2024

Summary

  • As of today (July 7, 2025), WVE annual cash flow from financing activities is $253.89 million, with the most recent change of +$121.36 million (+91.57%) on December 31, 2024.
  • During the last 3 years, WVE annual CFF has risen by +$198.06 million (+354.77%).
  • WVE annual CFF is now at all-time high.

Performance

WVE Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

quarterly CFF:

$4.16M-$30.83M(-88.12%)
March 31, 2025

Summary

  • As of today (July 7, 2025), WVE quarterly cash flow from financing activities is $4.16 million, with the most recent change of -$30.83 million (-88.12%) on March 31, 2025.
  • Over the past year, WVE quarterly CFF has dropped by -$10.36 million (-71.36%).
  • WVE quarterly CFF is now -97.96% below its all-time high of $203.75 million, reached on September 30, 2024.

Performance

WVE quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

TTM CFF:

$243.53M-$10.36M(-4.08%)
March 31, 2025

Summary

  • As of today (July 7, 2025), WVE TTM cash flow from financing activities is $243.53 million, with the most recent change of -$10.36 million (-4.08%) on March 31, 2025.
  • Over the past year, WVE TTM CFF has increased by +$131.54 million (+117.46%).
  • WVE TTM CFF is now -22.16% below its all-time high of $312.87 million, reached on September 30, 2024.

Performance

WVE TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

WVE Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+91.6%-71.4%+117.5%
3 y3 years+354.8%+215.7%+402.1%
5 y5 years+54.4%+576.7%+1772.5%

WVE Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+354.8%-98.0%>+9999.0%-22.2%+558.7%
5 y5-yearat high+354.8%-98.0%>+9999.0%-22.2%+1772.5%
alltimeall timeat high+6814.2%-98.0%+2746.5%-22.2%>+9999.0%

WVE Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$4.16M(-88.1%)
$243.53M(-4.1%)
Dec 2024
$253.89M(+91.6%)
$34.98M(-82.8%)
$253.89M(-18.9%)
Sep 2024
-
$203.75M(>+9900.0%)
$312.87M(+182.4%)
Jun 2024
-
$653.00K(-95.5%)
$110.80M(-1.1%)
Mar 2024
-
$14.51M(-84.6%)
$111.99M(-15.5%)
Dec 2023
$132.53M(+97.3%)
$93.96M(+5526.5%)
$132.53M(+243.1%)
Sep 2023
-
$1.67M(-9.7%)
$38.63M(+4.5%)
Jun 2023
-
$1.85M(-94.7%)
$36.97M(-63.4%)
Mar 2023
-
$35.05M(>+9900.0%)
$100.92M(+50.2%)
Dec 2022
$67.19M(+20.3%)
$55.00K(+223.5%)
$67.19M(-33.4%)
Sep 2022
-
$17.00K(-100.0%)
$100.93M(-7.6%)
Jun 2022
-
$65.80M(+4900.0%)
$109.26M(+125.3%)
Mar 2022
-
$1.32M(-96.1%)
$48.50M(-13.1%)
Dec 2021
$55.83M(-63.9%)
$33.79M(+304.8%)
$55.83M(+153.1%)
Sep 2021
-
$8.35M(+65.5%)
$22.05M(-85.9%)
Jun 2021
-
$5.04M(-41.6%)
$156.23M(-3.9%)
Mar 2021
-
$8.64M(>+9900.0%)
$162.56M(+5.2%)
Dec 2020
$154.54M(-6.0%)
$19.00K(-100.0%)
$154.54M(-0.5%)
Sep 2020
-
$142.52M(+1152.2%)
$155.28M(+1093.9%)
Jun 2020
-
$11.38M(+1753.7%)
$13.01M(+786.6%)
Mar 2020
-
$614.00K(-18.9%)
$1.47M(-99.1%)
DateAnnualQuarterlyTTM
Dec 2019
$164.40M(+152.6%)
$757.00K(+199.2%)
$164.40M(+0.1%)
Sep 2019
-
$253.00K(-261.1%)
$164.29M(-0.7%)
Jun 2019
-
-$157.00K(-100.1%)
$165.39M(-27.2%)
Mar 2019
-
$163.55M(>+9900.0%)
$227.10M(+248.9%)
Dec 2018
$65.09M(-31.0%)
$646.00K(-52.2%)
$65.09M(+0.1%)
Sep 2018
-
$1.35M(-97.8%)
$65.04M(+2.0%)
Jun 2018
-
$61.56M(+3905.2%)
$63.74M(-33.4%)
Mar 2018
-
$1.54M(+161.0%)
$95.72M(+1.4%)
Dec 2017
$94.37M(+224.1%)
$589.00K(+898.3%)
$94.37M(+0.6%)
Sep 2017
-
$59.00K(-99.9%)
$93.80M(-0.1%)
Jun 2017
-
$93.54M(>+9900.0%)
$93.92M(+220.3%)
Mar 2017
-
$190.00K(+1166.7%)
$29.33M(+0.7%)
Dec 2016
$29.12M(-83.4%)
$15.00K(-91.8%)
$29.12M(-77.9%)
Sep 2016
-
$184.00K(-99.4%)
$131.84M(-31.6%)
Jun 2016
-
$28.94M(<-9900.0%)
$192.87M(+17.6%)
Mar 2016
-
-$16.00K(-100.0%)
$163.95M(-6.6%)
Dec 2015
$175.59M(+3025.0%)
$102.74M(+67.8%)
$175.59M(+141.0%)
Sep 2015
-
$61.21M(>+9900.0%)
$72.86M(+525.6%)
Jun 2015
-
$15.00K(-99.9%)
$11.65M(+0.1%)
Mar 2015
-
$11.63M
$11.63M
Dec 2014
$5.62M(+53.0%)
-
-
Dec 2013
$3.67M
-
-

FAQ

  • What is Wave Life Sciences Ltd. annual cash flow from financing activities?
  • What is the all time high annual CFF for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. annual CFF year-on-year change?
  • What is Wave Life Sciences Ltd. quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. quarterly CFF year-on-year change?
  • What is Wave Life Sciences Ltd. TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. TTM CFF year-on-year change?

What is Wave Life Sciences Ltd. annual cash flow from financing activities?

The current annual CFF of WVE is $253.89M

What is the all time high annual CFF for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high annual cash flow from financing activities is $253.89M

What is Wave Life Sciences Ltd. annual CFF year-on-year change?

Over the past year, WVE annual cash flow from financing activities has changed by +$121.36M (+91.57%)

What is Wave Life Sciences Ltd. quarterly cash flow from financing activities?

The current quarterly CFF of WVE is $4.16M

What is the all time high quarterly CFF for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high quarterly cash flow from financing activities is $203.75M

What is Wave Life Sciences Ltd. quarterly CFF year-on-year change?

Over the past year, WVE quarterly cash flow from financing activities has changed by -$10.36M (-71.36%)

What is Wave Life Sciences Ltd. TTM cash flow from financing activities?

The current TTM CFF of WVE is $243.53M

What is the all time high TTM CFF for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high TTM cash flow from financing activities is $312.87M

What is Wave Life Sciences Ltd. TTM CFF year-on-year change?

Over the past year, WVE TTM cash flow from financing activities has changed by +$131.54M (+117.46%)
On this page